Biosimilars Will Get Regulatory Science Program, Supplement Timeline Changes In Next User Fee Agreement

The completed BsUFA III agreement includes supplement timeline improvements. • Source: Illustration
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics